Overview

Platelet Rich Plasma Market is estimated to value over USD 900 million by 2028 end with a CAGR of over 12.5% during the forecast period 2021 to 2028.

The platelet rich plasma is crucial for the healthcare industry, particularly in cosmetic and orthopedic surgical procedures. This procedure can treat injuries like tennis elbow, tendon cuffs, hamstring and rotator cuff, thereby healing the patient effectively. Furthermore, many sport-related injuries are healed with platelet rich plasma therapy. Even medical conditions like facelift surgeries and erectile dysfunction are also being treated using this therapy technique. The therapy includes collecting blood samples and separating the platelets using centrifuges. These platelets are then injected on the injury point for accelerating the process of healing. The procedure is allergy and risk-free as the blood used for the patient is of the patient itself.
Rising ageing population and growing prevalence of orthopedic conditions are some other factors propelling the platelet rich plasma market growth. AS pe the National Center for Biotechnology Information, over 1.4 million people are diagnosed with fractures related to osteoporosis every year. Additionally, rising awareness pertaining to platelet rich plasma therapy for dental treatment is predicted to boost the market proliferation.

Market Segmentation:

By Type

Pure Platelet-rich Plasma
Leukocyte Platelet-rich Plasma
Pure Platelet-rich Fibrin
Leukocyte Platelet-rich Fibrin

By Origin

Autologous Platelet-rich Plasma
Allogeneic Platelet-rich Plasma
Homologus Platelet-rich Plasma

By Application
• Cosmetic Surgery
o Skin Care
o Hair Care
• Orthopedic Surgery
• Ophthalmic Surgery
• Dentistry
• Cardiac Surgery
• Neurosurgery
• Other Indications

By Indication Stages
• Cosmetic Surgery
o Skin Care - Stage I, Stage II, Stage III, Stage IV
• Skin Ulcers
o Diabetic Foot Ulcer - Stage I, Stage II, Stage III, Stage IV
o Pressure Ulcer – Stage I, Stage II, Stage III, Stage IV
o Venous Insufficiency - Stage I, Stage II, Stage III
o Atherosclerosis – Stage I, Stage II, Stage III
o Hair Care
• Stage I
• Stage II
• Stage III
• Stage IV
• Orthopedic Surgery
o Stage I
o Stage II
o Stage III
o Stage IV
• Ophthalmic Surgery
o Stage I
o Stage II
o Stage III
o Stage IV
• Dentistry
o Stage I
o Stage II
o Stage III
o Stage IV
• Cardiac Surgery
o Stage I
o Stage II
o Stage III
o Stage IV
• Neurosurgery
o Stage I
o Stage II
o Stage III
o Stage IV

By End-User

Physician's office/Private Practice
Hospitals
Orthopedic Clinics
Ophthalmic Clinics
Cosmetic/Dermatology/Trichology Clinics
Academic & Research Institutes

By Region
•   North America
•   Latin America
•   Europe
•   Asia-Pacific
•   Middle East and Africa

The global market is classified into product, application and region. The product segment is fragmented into leukocyte rich PRP, pure PRP and leukocyte fibrin PRP. The pure PRP held the largest platelet rich plasma market share and it is predicted to do so during the forecast period. This is mainly due to its capability of eliminating neutrophils, a WBC type consisting of components that are inflammatory in nature, which is likely to cause pain once the treatment is completed. Conversely, the leukocyte-rich fibrin PRP is anticipated to grow substantially during the forecast period. This PRP technique improves the process of healing, thereby reducing the overall recovering time. Furthermore, they consist of organic healing proteins, which creates a cell network that accelerates the process of healing, thereby bettering the regeneration of bones.
The application segment is bifurcated into orthopaedics, ophthalmic surgery, cosmetic surgery and neurosurgery. The orthopaedics segment subjugated the market owing to arise in the number of patients diagnosed with orthopaedic conditions like tennis elbow, Achilles tendon injuries, rotator cuff, hamstring can be successfully treated with PRP. The technique helps in reducing injury recurrence which shall reduce the chance of surgical intervention.

Regional Analysis:

The North America region is predicted to subjugate the market owing to a wide range of applications along with a rise in the number of patients diagnosed with orthopaedic conditions. Furthermore, a strong presence of key market players is another factor bolstering the growth of the market.

Competitive Landscape:

Some of the key market players are T-Biotechnology (T-LAB), Arthrex, Inc., Terumo BCT, Inc., EmCyte Corporation, DePuy Synthes, Zimmer Biomet, Stryker; Glofinn Oy, DR. PRP AMERICA, LLC.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global platelet rich plasma market by type, by origin, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com